Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
353
-
Total shares
-
55.3M
-
Shares change
-
+520K
-
Total reported value, excl. options
-
$7.35B
-
Value change
-
+$36.6M
-
Put/Call ratio
-
2.2
-
Number of buys
-
175
-
Number of sells
-
-180
-
Price
-
$132.81
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2015
370 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q3 2015.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 353 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.3M shares
.
Largest 10 shareholders include PUTNAM INVESTMENTS LLC (10.1M shares), FMR LLC (9.13M shares), VANGUARD GROUP INC (3.96M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2.3M shares), Westpac Banking Corp (1.72M shares), BlackRock Fund Advisors (1.58M shares), BlackRock Institutional Trust Company, N.A. (1.47M shares), STATE STREET CORP (1.21M shares), JANUS CAPITAL MANAGEMENT LLC (1.07M shares), and Bank of New York Mellon Corp (1.03M shares).
This table shows the top 353 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.